Alkermes (NASDAQ:ALKS) Earns Neutral Rating from Analysts at UBS Group
UBS Group began coverage on shares of Alkermes (NASDAQ:ALKS – Free Report) in a research report report published on Tuesday, Marketbeat Ratings reports. The firm issued a neutral rating and a $31.00 price target on the stock. A number of other equities research analysts have also weighed in on the company. StockNews.com lowered Alkermes from […]